Finance
CureBay acquires Saveo’s pharma distribution business to expand rural reach
Deal adds 10,000+ pharmacy network and strengthens supply chain across southern India
Healthcare platform CureBay has acquired the pharmacy distribution business of Saveo Healthtech in a move aimed at strengthening medicine supply chains across semi-urban and underserved regions.
The deal brings into CureBay a network serving more than 10,000 retail pharmacies across southern India, along with distribution hubs in Bengaluru and Hyderabad, procurement systems and a technology-enabled ordering platform.
The financial terms of the transaction were not disclosed.
The acquisition reflects a broader trend among healthcare startups to gain control over critical parts of the value chain, particularly drug distribution, where stock-outs and fragmented logistics often disrupt patient care outside major cities.
CureBay, which operates over 190 eClinics across 15,000 villages, has served more than a million patients. The company stated that integrating Saveo’s distribution business will improve inventory visibility, reduce supply gaps and accelerate fulfilment cycles, particularly for chronic therapies and essential medicines.
“Medicines are central to continuity of care,” said Founder and Chief Executive Priyadarshi Mohapatra, adding that the deal would strengthen procurement capabilities and support faster expansion into new geographies.
The combined platform is expected to enable better demand planning and working capital management, areas that have historically limited pharmacy access in rural markets. CureBay has built its model around clustered expansion, with two clusters reportedly achieving operating profitability in eastern India.
For Saveo, the transaction marks a shift from operating an independent distribution network to becoming part of a broader healthcare delivery platform. Its existing pharmacy partners will continue within the integrated system, while CureBay’s clinics will benefit from a stronger backend supply chain.
As part of the transition, Saveo Co-founder Amit Kumar will lead pharmacy technology at CureBay, while senior executive Deepak Tiwary will oversee operations.
The move also highlights increasing consolidation in India’s fragmented pharmaceutical supply ecosystem, with startups combining digital capabilities and physical distribution to improve access in smaller towns.
Backed by investors such as Bertelsmann India Investments, Elevar Equity and British International Investment, CureBay is positioning itself as an integrated healthcare provider offering consultations, diagnostics and pharmacy services, particularly for underserved populations.
The deal brings into CureBay a network serving more than 10,000 retail pharmacies across southern India, along with distribution hubs in Bengaluru and Hyderabad, procurement systems and a technology-enabled ordering platform.
The financial terms of the transaction were not disclosed.
The acquisition reflects a broader trend among healthcare startups to gain control over critical parts of the value chain, particularly drug distribution, where stock-outs and fragmented logistics often disrupt patient care outside major cities.
CureBay, which operates over 190 eClinics across 15,000 villages, has served more than a million patients. The company stated that integrating Saveo’s distribution business will improve inventory visibility, reduce supply gaps and accelerate fulfilment cycles, particularly for chronic therapies and essential medicines.
“Medicines are central to continuity of care,” said Founder and Chief Executive Priyadarshi Mohapatra, adding that the deal would strengthen procurement capabilities and support faster expansion into new geographies.
The combined platform is expected to enable better demand planning and working capital management, areas that have historically limited pharmacy access in rural markets. CureBay has built its model around clustered expansion, with two clusters reportedly achieving operating profitability in eastern India.
For Saveo, the transaction marks a shift from operating an independent distribution network to becoming part of a broader healthcare delivery platform. Its existing pharmacy partners will continue within the integrated system, while CureBay’s clinics will benefit from a stronger backend supply chain.
As part of the transition, Saveo Co-founder Amit Kumar will lead pharmacy technology at CureBay, while senior executive Deepak Tiwary will oversee operations.
The move also highlights increasing consolidation in India’s fragmented pharmaceutical supply ecosystem, with startups combining digital capabilities and physical distribution to improve access in smaller towns.
Backed by investors such as Bertelsmann India Investments, Elevar Equity and British International Investment, CureBay is positioning itself as an integrated healthcare provider offering consultations, diagnostics and pharmacy services, particularly for underserved populations.
CureBayHealthcare StartupsPharma Distribution India
